Whole-body magnetic resonance angiography (WBMRA) as a tool for driving efficiency in the cost and treatment of claudication co-morbities

Danile Gassull, Duane Schulthess (Lead / Corresponding author), Stuart Suttie, Graeme Houston

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Whole-Body Magnetic Resonance Angiography (WBMRA) consists of a contrast-enhanced Magnetic Resonance Angiogram (MRA) scan of the entire body in a single step. In the diagnosis of cardiovascular co-morbidities in Peripheral Arterial Disease (PAD), the utilization of WBMRA can streamline the diagnostic process by minimizing the usage of MRA, CT, and Angiograms. In this work, the potential cost savings to the hospital by using WBMRA in PAD are modeled based on collected data that accounts for all interventions in the radiological department of a set of 50 patients with Claudication in the period 2008-2012 at Ninewells Hospital (NHS Tayside). As the application of WBMRA is only marginally more expensive than lower-limb MRA, a large gain in efficiency is possible by eliminating unneeded MRA by 25% and Angiograms by 30% as well as several steps of consultations. We estimate that this can save up to £1.2M in NHS Tayside and Fife, £7.5M in Scotland and £90M in UK per annum. In addition, WBMRA can save £20M per year in the UK in the treatment of Diabetes.
Original languageEnglish
Pages (from-to)181-187
Number of pages7
JournalHealth Policy and Technology
Volume2
Issue number4
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Angiography
Magnetic Resonance Angiography
Magnetic resonance
Health Care Costs
Magnetic Resonance Spectroscopy
Costs
Peripheral Arterial Disease
Cost Savings
Scotland
Lower Extremity
Referral and Consultation
Medical problems
Morbidity

Cite this

@article{4a5261146e5c4a958e600d1a1bbb460c,
title = "Whole-body magnetic resonance angiography (WBMRA) as a tool for driving efficiency in the cost and treatment of claudication co-morbities",
abstract = "The Whole-Body Magnetic Resonance Angiography (WBMRA) consists of a contrast-enhanced Magnetic Resonance Angiogram (MRA) scan of the entire body in a single step. In the diagnosis of cardiovascular co-morbidities in Peripheral Arterial Disease (PAD), the utilization of WBMRA can streamline the diagnostic process by minimizing the usage of MRA, CT, and Angiograms. In this work, the potential cost savings to the hospital by using WBMRA in PAD are modeled based on collected data that accounts for all interventions in the radiological department of a set of 50 patients with Claudication in the period 2008-2012 at Ninewells Hospital (NHS Tayside). As the application of WBMRA is only marginally more expensive than lower-limb MRA, a large gain in efficiency is possible by eliminating unneeded MRA by 25{\%} and Angiograms by 30{\%} as well as several steps of consultations. We estimate that this can save up to £1.2M in NHS Tayside and Fife, £7.5M in Scotland and £90M in UK per annum. In addition, WBMRA can save £20M per year in the UK in the treatment of Diabetes.",
author = "Danile Gassull and Duane Schulthess and Stuart Suttie and Graeme Houston",
note = "This study was funded in part by Grants from the Chief Scientist Office of the NHS Scotland, The University of Dundee and NHS Tayside.",
year = "2013",
month = "12",
doi = "10.1016/j.hlpt.2013.08.003",
language = "English",
volume = "2",
pages = "181--187",
journal = "Health Policy and Technology",
issn = "2211-8837",
publisher = "Elsevier",
number = "4",

}

Whole-body magnetic resonance angiography (WBMRA) as a tool for driving efficiency in the cost and treatment of claudication co-morbities. / Gassull, Danile; Schulthess, Duane (Lead / Corresponding author); Suttie, Stuart; Houston, Graeme.

In: Health Policy and Technology, Vol. 2, No. 4, 12.2013, p. 181-187.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Whole-body magnetic resonance angiography (WBMRA) as a tool for driving efficiency in the cost and treatment of claudication co-morbities

AU - Gassull, Danile

AU - Schulthess, Duane

AU - Suttie, Stuart

AU - Houston, Graeme

N1 - This study was funded in part by Grants from the Chief Scientist Office of the NHS Scotland, The University of Dundee and NHS Tayside.

PY - 2013/12

Y1 - 2013/12

N2 - The Whole-Body Magnetic Resonance Angiography (WBMRA) consists of a contrast-enhanced Magnetic Resonance Angiogram (MRA) scan of the entire body in a single step. In the diagnosis of cardiovascular co-morbidities in Peripheral Arterial Disease (PAD), the utilization of WBMRA can streamline the diagnostic process by minimizing the usage of MRA, CT, and Angiograms. In this work, the potential cost savings to the hospital by using WBMRA in PAD are modeled based on collected data that accounts for all interventions in the radiological department of a set of 50 patients with Claudication in the period 2008-2012 at Ninewells Hospital (NHS Tayside). As the application of WBMRA is only marginally more expensive than lower-limb MRA, a large gain in efficiency is possible by eliminating unneeded MRA by 25% and Angiograms by 30% as well as several steps of consultations. We estimate that this can save up to £1.2M in NHS Tayside and Fife, £7.5M in Scotland and £90M in UK per annum. In addition, WBMRA can save £20M per year in the UK in the treatment of Diabetes.

AB - The Whole-Body Magnetic Resonance Angiography (WBMRA) consists of a contrast-enhanced Magnetic Resonance Angiogram (MRA) scan of the entire body in a single step. In the diagnosis of cardiovascular co-morbidities in Peripheral Arterial Disease (PAD), the utilization of WBMRA can streamline the diagnostic process by minimizing the usage of MRA, CT, and Angiograms. In this work, the potential cost savings to the hospital by using WBMRA in PAD are modeled based on collected data that accounts for all interventions in the radiological department of a set of 50 patients with Claudication in the period 2008-2012 at Ninewells Hospital (NHS Tayside). As the application of WBMRA is only marginally more expensive than lower-limb MRA, a large gain in efficiency is possible by eliminating unneeded MRA by 25% and Angiograms by 30% as well as several steps of consultations. We estimate that this can save up to £1.2M in NHS Tayside and Fife, £7.5M in Scotland and £90M in UK per annum. In addition, WBMRA can save £20M per year in the UK in the treatment of Diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84887169958&partnerID=8YFLogxK

U2 - 10.1016/j.hlpt.2013.08.003

DO - 10.1016/j.hlpt.2013.08.003

M3 - Article

VL - 2

SP - 181

EP - 187

JO - Health Policy and Technology

JF - Health Policy and Technology

SN - 2211-8837

IS - 4

ER -